---
title: Carisoprodol
description: >-
  Carisoprodol is a centrally-acting skeletal muscle relaxant indicated for the
  short-term (up to two or three weeks) relief of discomfort associated with
  acute, painful musculoskeletal conditions in adults. Its efficacy for more
  extended periods has not been established.
is_banned: false
lastModified: '2025-09-22T17:21:52.510Z'
faqs:
  - q: >-
      What is the recommended dosage for Carisoprodol?**


      **A:** Adults and children over 16: 250-350 mg orally three times a day
      and at bedtime. Maximum daily dose: 1400 mg. Not recommended for children
      under 16.
    a: >-
      A:** Adults and children over 16: 250-350 mg orally three times a day and
      at bedtime. Maximum daily dose: 1400 mg. Not recommended for children
      under 16.
  - q: |-
      What is the maximum duration of therapy for Carisoprodol?**

      **A:** Carisoprodol should only be used for up to two to three weeks.
    a: 'A:** Carisoprodol should only be used for up to two to three weeks.'
  - q: >-
      Is Carisoprodol safe during pregnancy?**


      **A:**  Carisoprodol is Pregnancy Category C.  Use only if the potential
      benefit justifies the potential risk to the fetus.
    a: >-
      A:**  Carisoprodol is Pregnancy Category C.  Use only if the potential
      benefit justifies the potential risk to the fetus.
  - q: >-
      Can Carisoprodol be used in patients with liver or kidney problems?**


      **A:** Use with caution in patients with hepatic or renal impairment. 
      Dose adjustments may be necessary.
    a: >-
      A:** Use with caution in patients with hepatic or renal impairment.  Dose
      adjustments may be necessary.
  - q: |-
      What are the common side effects of Carisoprodol?**

      **A:**  Drowsiness, dizziness, and headache are common side effects.
    a: 'A:**  Drowsiness, dizziness, and headache are common side effects.'
  - q: >-
      Does Carisoprodol interact with other medications?**


      **A:**  Yes, Carisoprodol can interact with other CNS depressants
      (alcohol, benzodiazepines, opioids) and drugs metabolized by CYP2C19.
    a: >-
      A:**  Yes, Carisoprodol can interact with other CNS depressants (alcohol,
      benzodiazepines, opioids) and drugs metabolized by CYP2C19.
  - q: >-
      Can patients drive or operate machinery while taking Carisoprodol?**


      **A:**  No, Carisoprodol can cause drowsiness and impair cognitive
      function.  Patients should avoid activities requiring alertness.
    a: >-
      A:**  No, Carisoprodol can cause drowsiness and impair cognitive
      function.  Patients should avoid activities requiring alertness.
  - q: >-
      Is Carisoprodol addictive?**


      **A:**  Yes, Carisoprodol has the potential for abuse and dependence. Use
      should be limited to short-term treatment, and patients with a history of
      substance abuse should be monitored carefully.
    a: >-
      A:**  Yes, Carisoprodol has the potential for abuse and dependence. Use
      should be limited to short-term treatment, and patients with a history of
      substance abuse should be monitored carefully.
  - q: >-
      What should be done in case of a Carisoprodol overdose?**


      **A:** Seek immediate medical attention. Overdose symptoms may include CNS
      depression, coma, respiratory depression, hypotension, seizures, and other
      serious effects.
    a: >-
      A:** Seek immediate medical attention. Overdose symptoms may include CNS
      depression, coma, respiratory depression, hypotension, seizures, and other
      serious effects.
  - q: >-
      What is the mechanism of action of Carisoprodol?**


      **A:** The exact mechanism is unknown, but it is believed to work as a CNS
      depressant, affecting neuronal transmission in the reticular formation and
      spinal cord.
    a: >-
      A:** The exact mechanism is unknown, but it is believed to work as a CNS
      depressant, affecting neuronal transmission in the reticular formation and
      spinal cord.
---
## **Usage**

Carisoprodol is a centrally-acting skeletal muscle relaxant indicated for the short-term (up to two or three weeks) relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Its efficacy for more extended periods has not been established.

## **Alternate Names**

* International Nonproprietary Name (INN): Carisoprodol
* Brand names: Soma, Vanadom

## **How It Works**

**Pharmacodynamics:** Carisoprodol's precise mechanism of action is not fully understood, but it is believed to work by depressing the central nervous system (CNS), specifically within the reticular formation and spinal cord, leading to muscle relaxation and pain relief. Its primary metabolite, meprobamate, has anxiolytic properties and may contribute to the overall effect.

**Pharmacokinetics:**
* **Absorption:** Carisoprodol is rapidly absorbed after oral administration.
* **Metabolism:** It is extensively metabolized in the liver, primarily by the CYP2C19 enzyme, into meprobamate and other metabolites.
* **Elimination:** Carisoprodol and its metabolites are primarily excreted in the urine. It is dialyzable by hemodialysis and peritoneal dialysis.

**Mode of Action:**  Carisoprodol's mechanism of action is not entirely clear, although it is thought to disrupt neuronal transmission at interneuronal synapses within the descending reticular formation and spinal cord, thereby decreasing neuronal excitability. The exact mode of binding or interactions with specific receptors or enzymes is not well-defined.

**Elimination Pathways:** Carisoprodol is eliminated mainly through hepatic metabolism and subsequent renal excretion of metabolites.


## **Dosage**

### **Standard Dosage**

#### **Adults:**  250-350 mg orally three times a day and at bedtime. Maximum daily dose: 1400 mg.

#### **Children:** Not recommended for use in children under 16 years of age. For individuals 16 years and older, the dosage is the same as for adults.

#### **Special Cases:**

* **Elderly Patients (over 65):** Use with caution due to increased risk of orthostatic hypotension and CNS depression.  Safety and efficacy have not been established.
* **Patients with Renal Impairment:** Use with caution.  Dose adjustment may be necessary.
* **Patients with Hepatic Dysfunction:** Use with caution. Dose adjustment may be necessary.
* **Patients with Comorbid Conditions:** Consider potential drug interactions and adjust accordingly.

### **Clinical Use Cases**

Carisoprodol is not indicated for use in clinical settings like intubation, surgical procedures, mechanical ventilation, ICU use, or emergency situations. Its use is specifically for acute musculoskeletal pain relief as an adjunct to rest and physical therapy.

### **Dosage Adjustments**

Dose adjustments may be needed for patients with renal or hepatic impairment. For patients with reduced CYP2C19 activity, caution is advised, as they may have higher carisoprodol and lower meprobamate exposure.


## **Side Effects**

### **Common Side Effects:**

* Drowsiness
* Dizziness
* Headache


### **Rare but Serious Side Effects:**

* Allergic reactions (rash, itching, swelling, difficulty breathing)
* Seizures
* Serotonin syndrome (agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, diarrhea)


### **Long-Term Effects:**

Potential for dependence and withdrawal symptoms with prolonged use.

### **Adverse Drug Reactions (ADR):**

Severe allergic reactions, seizures, and serotonin syndrome require immediate medical attention.



## **Contraindications**

* Hypersensitivity to carisoprodol or meprobamate
* Acute intermittent porphyria



## **Drug Interactions**

Carisoprodol interacts with CNS depressants (e.g., alcohol, benzodiazepines, opioids), potentially leading to additive sedative effects. It can also interact with certain medications metabolized by CYP2C19 (e.g., some antidepressants, anticoagulants). Caution is advised when combining carisoprodol with other drugs, OTC medications, or supplements.  Consult a comprehensive drug interaction resource for a full list of potential interactions.


## **Pregnancy and Breastfeeding**

* **Pregnancy:** Pregnancy Category C.  Use only if the potential benefit outweighs the potential risk to the fetus. 
* **Breastfeeding:** Carisoprodol is excreted in breast milk. Monitor infants for sedation and consider the risks and benefits of breastfeeding while taking carisoprodol.


## **Drug Profile Summary**

* **Mechanism of Action:**  CNS depressant, exact mechanism unknown.
* **Side Effects:** Drowsiness, dizziness, headache; rarely, allergic reactions, seizures, serotonin syndrome.
* **Contraindications:** Hypersensitivity, acute intermittent porphyria.
* **Drug Interactions:** CNS depressants, CYP2C19 substrates/inhibitors.
* **Pregnancy & Breastfeeding:** Use with caution.  Potential fetal risks and infant sedation.
* **Dosage:** Adults/Children (16+): 250-350 mg three times daily and at bedtime. Max 1400 mg/day. Duration up to 2-3 weeks.
* **Monitoring Parameters:** Monitor for sedation, signs of abuse or overdose, and allergic reactions.


## **Popular Combinations**

Carisoprodol is not typically used in combination with other drugs for synergistic effects due to the risk of additive adverse effects. Its use focuses on short-term pain relief as part of a broader treatment plan including rest and physical therapy.


## **Precautions**

* Screen for allergies, history of substance abuse, and renal/hepatic impairment.
* Avoid alcohol and other CNS depressants.
* Use caution in elderly patients.
* Advise patients against driving or operating machinery while taking carisoprodol.


## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Carisoprodol?**

**A:** Adults and children over 16: 250-350 mg orally three times a day and at bedtime. Maximum daily dose: 1400 mg. Not recommended for children under 16.


### **Q2: What is the maximum duration of therapy for Carisoprodol?**

**A:** Carisoprodol should only be used for up to two to three weeks.


### **Q3: Is Carisoprodol safe during pregnancy?**

**A:**  Carisoprodol is Pregnancy Category C.  Use only if the potential benefit justifies the potential risk to the fetus.


### **Q4: Can Carisoprodol be used in patients with liver or kidney problems?**

**A:** Use with caution in patients with hepatic or renal impairment.  Dose adjustments may be necessary.


### **Q5: What are the common side effects of Carisoprodol?**

**A:**  Drowsiness, dizziness, and headache are common side effects.


### **Q6:  Does Carisoprodol interact with other medications?**

**A:**  Yes, Carisoprodol can interact with other CNS depressants (alcohol, benzodiazepines, opioids) and drugs metabolized by CYP2C19.


### **Q7: Can patients drive or operate machinery while taking Carisoprodol?**

**A:**  No, Carisoprodol can cause drowsiness and impair cognitive function.  Patients should avoid activities requiring alertness.


### **Q8: Is Carisoprodol addictive?**

**A:**  Yes, Carisoprodol has the potential for abuse and dependence. Use should be limited to short-term treatment, and patients with a history of substance abuse should be monitored carefully.


### **Q9: What should be done in case of a Carisoprodol overdose?**

**A:** Seek immediate medical attention. Overdose symptoms may include CNS depression, coma, respiratory depression, hypotension, seizures, and other serious effects.


### **Q10:  What is the mechanism of action of Carisoprodol?**

**A:** The exact mechanism is unknown, but it is believed to work as a CNS depressant, affecting neuronal transmission in the reticular formation and spinal cord.
